Send to

Choose Destination
Neurobiol Aging. 2013 Dec;34(12):2890.e1-5. doi: 10.1016/j.neurobiolaging.2013.06.005. Epub 2013 Jul 17.

Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family.

Author information

Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK. Electronic address:


Triggering receptor expressed on myeloid cells 2 (TREM2) homozygous mutations cause Nasu-Hakola disease, an early-onset recessive form of dementia preceded by bone cysts and fractures. The same type of mutations has recently been shown to cause frontotemporal dementia (FTD) without the presence of any bone phenotype. Here, we further confirm the association of TREM2 mutations with FTD-like phenotypes by reporting the first compound heterozygous mutation in a Turkish family.


Compound heterozygous; Frontotemporal dementia; Nasu-Hakola; TREM2

[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center